Vagus nerve stimulation is a medical treatment, and it includes delivering electrical impulses to the vagus nerve. It is used as an add-on treatment for several types of intractable epilepsy and treatment-resistant depression. Common side effects include coughing and shortness of breath.
MARKET DYNAMICS
The vagus nerve stimulator market is driving due to the research for treatment and gene delivery using vectors as carriers for neurological disorders. Moreover, the rising burden of neurological diseases especially in emerging countries is a key factor behind the growth of this market.
MARKET SCOPE
The "Vagus Nerve Stimulator Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of vagus nerve stimulator market with detailed market segmentation by product, application, end user and biomaterial. The vagus nerve stimulator market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in vagus nerve stimulator market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The vagus nerve stimulator market is segmented on the basis of product, application, end user and biomaterial. Based on product, the market is segmented as implantable VNS devices and external VNS devices. On the basis of application, the market is categorized as depression, epilepsy, and migraine. On the basis of end user, the market is categorized as hospitals, ambulatory surgical centers (ASCs), and others. On the basis of bio material the market is categorized as ceramics, metallic, and polymeric.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the vagus nerve stimulator market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The vagus nerve stimulator market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting vagus nerve stimulator market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the vagus nerve stimulator market in these regions.
MARKET PLAYERS
The report covers key developments in the vagus nerve stimulator market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from vagus nerve stimulator market are anticipated to have lucrative growth opportunities in the future with the rising demand for vagus nerve stimulator in the global market. Below mentioned is the list of few companies engaged in the vagus nerve stimulator market.
The report also includes the profiles of key players in vagus nerve stimulator market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Aleva Neurotherapeutics SA
- BioControl Medical
- Bioness Inc.
- Boston Scientific Corporation
- ElectroCore LLC
- EnteroMedics Inc.
- LivaNova Plc.
- Medtronic Plc.
- NeuroPace Inc.
- Nevro Corporation